Beneficial interest AvH: 15.9% (not consolidated)
AvH contact: Jens Van Nieuwenborgh
MRM Health, established in the Ghent biotech cluster, develops innovative human microbiome-based medicines.
Beneficial interest AvH: 15.9% (not consolidated)
AvH contact: Jens Van Nieuwenborgh
MRM Health, established in the Ghent biotech cluster, develops innovative human microbiome-based medicines.